What Catalysts Are Shaping the Evolving Story for Synchrony Financial

Synchrony Financial’s fair value estimate has experienced a minor uptick, moving from $81.39 to $82.39, following recent analyst revisions. This change reflects a mix of renewed optimism regarding the company’s sustained revenue generation along with cautious attention to ongoing credit trends and consumer health. Stay tuned to discover the key factors driving these updates and learn how to track the evolving story as it unfolds.

???? Bullish Takeaways

Multiple analysts raised their price targets on Synchrony Financial in recent weeks, reflecting renewed confidence in the company's growth trajectory and credit performance. Deutsche Bank notably increased its target twice, first to $93 and then to $95, maintaining a Buy rating as the market grows more comfortable with stabilized credit and the expectation of returning revenue growth.

Barclays demonstrated sustained optimism, lifting its price target to $86 from $83. The firm cited improved fiscal 2027 projections due to additional share buybacks, slightly better credit performance, and upside from new partnerships such as the Walmart launch.

BofA raised its price target to $84, highlighting strengthened consumer spending trends and signaling confidence that loan growth has likely bottomed out, with expectations for a meaningful acceleration next year.

Citizens JMP raised its target to $88, referencing management's positive commentary around credit metrics and strong results through August. This increases confidence in credit quality for the coming year.

Other firms, including Morgan Stanley, Truist, and UBS, also raised their targets, pointing to improving sector conditions, robust capital markets, and better-than-expected loan and credit dynamics. However, some maintained neutral or hold ratings, citing ongoing caution around sector valuations.

???? Bearish Takeaways

Despite broad optimism, JPMorgan downgraded Synchrony to Neutral from Overweight and reduced its price target to $75 from $80. The firm points to Synchrony's potentially weaker position among consumer credit card issuers and concerns over higher delinquency rates as reasons for a more conservative stance.

Some neutral-rated analysts, such as those at UBS and Truist, acknowledge the company's solid operational execution but urge selectivity after recent share price appreciation. These analysts reference valuation concerns and the possibility that much of the near-term upside may already be reflected in the current stock price.

Overall, while the analyst consensus shows increased optimism regarding Synchrony Financial's ability to execute and capitalize on growth opportunities, notably in credit performance and new partnerships, there remains a contingent concerned with valuation levels and competitive positioning in the consumer finance sector. These factors continue to influence the evolving view of the company's fair value and long-term prospects.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

Deutsche Bank has raised its price target on Synchrony Financial to $93 from $91 and maintained its Buy rating. The decision follows positive third-quarter results, which reinforced expectations for resumed revenue growth and stable credit performance.

Synchrony Financial reported a significant decline in net charge-offs for the third quarter of 2025, recording $1,298 million compared to $1,553 million in the same period last year.

The company completed a major share buyback during the third quarter, repurchasing 11.87 million shares for $861 million. This brings the total number of shares repurchased under its current authorization to 20.7 million, representing 5.51 percent of shares outstanding.

Synchrony expanded its CareCredit business through new partnerships with Pumpkin Pet Insurance and mClub LLC, aiming to enhance financing options for veterinary care providers and pet owners.

Fair Value Estimate has risen slightly from $81.39 to $82.39, reflecting modest upward adjustments in analyst models.

Discount Rate has decreased marginally from 9.27% to 9.20%, indicating a small reduction in perceived risk or cost of capital.

Revenue Growth projections have fallen moderately from 21.65% to 19.85%, suggesting slightly tempered expectations for topline expansion.

Net Profit Margin forecasts have declined from 19.61% to 18.26%, which points to a lower anticipated level of profitability.

Future P/E Ratio has decreased from 10.61x to 10.23x. This may reflect adjustments in forward earnings estimates or valuation assumptions.

A Narrative is more than just numbers; it’s your story behind a company’s fair value, revenue, and earnings forecasts. Narratives connect the “why” with the “what,” letting you map out assumptions, track updates, and decide when to act. They are dynamic, easy to use, and available to millions of investors on Simply Wall St’s Community page, helping you quickly see if Fair Value aligns with Price as news and results evolve.

See the full story for yourself: Read the original Synchrony Financial Narrative to stay informed on:

How new retail partnerships and digital programs are fueling recurring revenue, customer retention, and earnings stability.

The impact of cutting-edge tech investments such as AI and embedded finance on risk management, sustainable growth, and operational efficiency.

The key risks, including market competition, reliance on major partners, regulatory shifts, and changing consumer behavior, that could challenge long-term profitability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SYF.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Scroll to Top